KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in Net LoansChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Morgan Stanley (MS) Gains from Sales and Divestitures (2016 - 2018)

Morgan Stanley (MS) has disclosed Gains from Sales and Divestitures for 9 consecutive years, with $27.0 million as the latest value for Q4 2018.

  • On a quarterly basis, Gains from Sales and Divestitures fell 20.59% to $27.0 million in Q4 2018 year-over-year; TTM through Dec 2018 was $27.0 million, a 20.59% decrease, with the full-year FY2018 number at $27.0 million, down 20.59% from a year prior.
  • Gains from Sales and Divestitures was $27.0 million for Q4 2018 at Morgan Stanley, down from $34.0 million in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $48.0 million in Q4 2014 to a low of $27.0 million in Q4 2018.
  • A 5-year average of $39.4 million and a median of $40.0 million in 2016 define the central range for Gains from Sales and Divestitures.
  • Peak YoY movement for Gains from Sales and Divestitures: soared 33.33% in 2014, then dropped 20.59% in 2018.
  • Morgan Stanley's Gains from Sales and Divestitures stood at $48.0 million in 2014, then changed by 0.0% to $48.0 million in 2015, then fell by 16.67% to $40.0 million in 2016, then fell by 15.0% to $34.0 million in 2017, then fell by 20.59% to $27.0 million in 2018.
  • Per Business Quant, the three most recent readings for MS's Gains from Sales and Divestitures are $27.0 million (Q4 2018), $34.0 million (Q4 2017), and $40.0 million (Q4 2016).